Accelerating Gene Therapies? There’s an ETF for That

Within the fast-growing genomics universe, one of the more compelling themes is the evolution of gene therapies – a theme the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is levered to. Relative to passive genomics exchange traded funds, the actively managed ARKG can more rapidly adjust...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.